ArticleMolecular therapy : the journal of the American Society of Gene Therapy2010

Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenoviruses.

Juan J Rojas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.